Diuresis

Diuresis" refers to the physiological process of increased urine production by the kidneys. It is not a molecule, receptor, enzyme, transporter, or any other type of therapeutic target. Instead, it describes an outcome that can be induced by various drugs—most notably diuretics—or occur as part of certain diseases or physiological states[1][6]. Diuretic drugs promote diuresis by inhibiting sodium reabsorption at different segments of the renal tubule system[1][3][4]. The term "diuresis" itself does not refer to a specific molecular entity and therefore cannot be classified as a drug target.\n\nNote: Drugs such as loop diuretics (e.g., furosemide), thiazides (e.g., hydrochlorothiazide), and others induce diuresis but do so by acting on specific molecular targets like transporters in the kidney[1][5][6]. The mechanisms of action and safety concerns relate to those drug targets—not to "diuresis" itself.\n\nSummary: There is something incorrect with using "Diuresis" as a therapeutic target name. It should instead refer to specific proteins or transporters involved in mediating this effect—such as "Sodium-potassium-chloride cotransporter," "Sodium-chloride symporter," etc.—depending on context[1][3][6].

Other names

diuresisincreased urine outputwater lossnatriuresis (contextual)